我国医药知识产权保护现状分析与对策研究

【作者】 杜方冬；

【导师】 罗爱静；

【作者基本信息】 中南大学 ， 情报学， 2003， 硕士

【摘要】 本文通过问卷调查法、对比分析法对我国医药专利保护现状、国外企业来华医药专利申请情况及我国医药企业医药专利申请情况进行了分析。结果表明，目前我国医药知识产权现状与国外差距明显。 本文将我国现行知识产权制度与国际知识产权制度在专利保护、商标保护、著作权及反不正当竞争法方面进行了比较，结果表明，由于我国近几年对知识产权相关法律法规进行了较大程度的修改，绝大部分的条款已经符合或接近于国际知识产权制度，差距正在进一步缩小。 本文还在药物专利保护方面进行了国内外比较，结果表明，由于我国的专利法已经按照TRIPs协议的要求进行了修改，因此，我国与这些国家在制度上的差异并不明显，在制度上基本与发达国家看齐。 针对我国医药知识产权保护在法律制度上已与国际接轨，而医药知识产权现状与国外差距甚远的现象，为加强我国医药知识产权保护、促进我国医药事业的发展，提出了专利策略、商标策略、商业秘密策略、网络环境下医药知识产权保护策略及标准化策略，并为完善我国医药知识产权保护制度提出了建议。更多还原

【Abstract】 Via a mail survey and comparative analysis, the paper has carried out a deep-going study on the status quo of medical and pharmaceutical patent protection in China, foreign and internal enterprises’ application for medical and pharmaceutical patent in China. The study shows that there is an apparent gap between China and Developed countries in medical and pharmaceutical intellectual property protection.From the aspects of the patent protection, trademark protection, copyright protection and anti-unlawful competition law, the paper compares the current intellectual properly system in China with the international ones. Due to the intensive and large-scale modification or amendment to laws and regulations related to intellectual property in China in recent years, most of the provisions or articles are now conformed to or approximate to international intellectual property system. The gap between them is shrinking.A comparison on the patent protection of medicines between China and developed countries are also carried out in this paper. The result shows that the difference between the two parties is not very obvious as China has amended the patent law according to the TRIPs.In view of the reality that our medical and pharmaceutical intellectual property protection has kept pace with that of the world in laws and regulations but far from it in practice, in order to enhance the medical and pharmaceutical intellectual property protection and promote the development of medical and pharmaceutical industry in China, the paper presents the strategies of patent, trademark, commercial secret, standardization and that of medical and pharmaceutical intellectual property protection in the network environment. Besides, the paper offers suggestions as how to improve the medical and pharmaceutical intellectual property protection in China.更多还原